Weight Loss Reduces Severity of Psoriasis

Published Online: Monday, June 24, 2013
Follow Pharmacy_Times:
Weight loss may help relieve psoriasis symptoms in obese patients, according to a study published online on May 29, 2013, by JAMA Dermatology. Sixty obese patients diagnosed with psoriasis were either restricted to a low calorie diet for 16 weeks or were instructed to eat healthy foods. Patients in the low calorie group improved their Psoriasis Area and Severity Index and Dermatology Life Quality Index scores.

Related Articles
A long-term study of Celgene Corporation’s apremilast showed that the oral selective inhibitor of phosphodiesterase 4 provides relief to adult patients with active psoriatic arthritis, as well as adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
AstraZeneca and Amgen tracked psoriasis patients taking brodalumab, ustekinumab (Stelara), or placebo, and the results showed brodalumab produced the greatest results in clearing skin.
The FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of Novartis’ first-in-class secukinumab therapy for moderate-to-severe plaque psoriasis.
Patients with moderate-to-severe psoriasis are more likely to have uncontrolled hypertension.
Latest Issues
$auto_registration$